Generex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines

    NEXT STORY
    Onxeo to Present Next-Generation PARP inhibitor, OX401, at the European ESMO-TAT Congress 2020
    PREV STORY
    How Best to Fix the US Healthcare System? For Physicians, It Starts with Affordability and Access, Says InCrowd Data
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights

    WATERTOWN, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Investigational Ebola Vaccine from Janssen and Bavarian Nordic to Support Outbreak Response in Democratic Republic of the Congo

    author_avatar
    NASDAQ Market News

    FDA approves Roche’s Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer

    author_avatar
    NASDAQ Market News